Showing results (141-150 of 192) with videos related to
Sort By:
Pageof 20
Blood|June 4, 2008
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimenGinna G Laport, Joseph C Alvarnas, Joycelynne M Palmer, et al.Transplantation|March 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remissionK G Blume, S J Forman, D S Snyder, et al.Journal of Clinical Immunology|May 10, 2002
Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectivesMarco Mielcarek, Brenda M Sandmaier, David G Maloney, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2000
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantationT M Cao, R S Negrin, K E Stockerl-Goldstein, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphomaJ C Alvarnas, R S Negrin, S J Horning, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2001
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centersR Storb, K G Blume, M R O'Donnell, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's diseaseM J Stuart, N S Chao, S J Horning, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2002
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II studyBorje S Andersson, Ashwin Kashyap, Victor Gian, et al.Blood|July 2, 2002
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialMary E D Flowers, Pablo M Parker, Laura J Johnston, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2001
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experienceT M Cao, S Horning, R S Negrin, et al.Pageof 20